Headway Seen In EU-India FTA Talks, Commerce Ministry Joint Secretary Says
This article was originally published in PharmAsia News
Executive Summary
Disputes over EU blockades of Indian drug shipments are still on the negotiation table, says Commerce Ministry. India hopes to initiate talks with China as well.
You may also be interested in...
Chinese Government Takes First Steps To De-link Indigenous Innovation And Procurement, But Industry Groups Wary
SHANGHAI - Months after pledging a policy change, China is finally taking steps to break ties between indigenous innovation and government procurement policies. The changes in policy, according to a report released by the U.S.-China Business Council, address growing concern among multinationals that procurement policies - an estimated $1 trillion market - are increasingly designed to shut them out
India, Japan Shake Hands For Faster Entry Of Generics But Market Realities May Be Tougher To Handle
MUMBAI/TOKYO - Introduction of non-discriminatory or national treatment clauses for Indian generic companies in the latest trade agreement between India and Japan will facilitate wider access for Indian generic firms to the world's second-largest pharma market, but analysts predict headwinds await before companies get a real bang for their buck
Indian Lobby Warns Of Proposed EU-India Free Trade Agreement's Impact; Says Drug Supplies Of Developing Nations May Be In Jeopardy
MUMBAI - As India and the European Union draw closer to signing a comprehensive Free Trade Agreement, the Indian Pharmaceutical Alliance - an influential lobby group of leading Indian pharmaceutical companies - has appealed to the Indian government to exercise caution and abstain from giving in to EU's demands, particularly those that allegedly ask for "TRIPS plus" provisions to be incorporated in the Indian legal framework